Rockefeller Capital Management
PCRX icon

Rockefeller Capital Management’s Pacira BioSciences PCRX Stock Holding History

Rockefeller Capital Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.4K Sell
1,078
-465
-30% -$11K ﹤0.01% 3631
2026
Q1 		$34.9K Buy
1,543
+655
+74% +$14.6K ﹤0.01% 3450
2025
Q4 		$23K Sell
888
-983
-53% -$23.4K ﹤0.01% 3445
2025
Q3 		$48.2K Buy
+1,871
New +$46K ﹤0.01% 2933
2023
Q1 		– Sell
-637
Closed -$24K – 3333
2022
Q4 		$24K Sell
637
-278
-30% -$13.5K ﹤0.01% 2734
2022
Q3 		$48K Sell
915
-149
-14% -$8.29K ﹤0.01% 2371
2022
Q2 		$61K Buy
1,064
+81
+8% +$5.31K ﹤0.01% 2197
2022
Q1 		$75K Buy
983
+7
+0.7% +$467 ﹤0.01% 2117
2021
Q4 		$58K Sell
976
-189
-16% -$10.4K ﹤0.01% 2150
2021
Q3 		$65K Buy
1,165
+32
+3% +$1.84K ﹤0.01% 2021
2021
Q2 		$68K Buy
1,133
+83
+8% +$5.25K ﹤0.01% 1946
2021
Q1 		$73K Buy
1,050
+13
+1% +$929 ﹤0.01% 1746
2020
Q4 		$62K Buy
1,037
+133
+15% +$7.79K ﹤0.01% 1610
2020
Q3 		$54K Buy
904
+603
+200% +$35K ﹤0.01% 1486
2020
Q2 		$16K Sell
301
-62
-17% -$2.59K ﹤0.01% 1747
2020
Q1 		$12K Buy
363
+163
+82% +$6.77K ﹤0.01% 1691
2019
Q4 		$9K Hold
200
– – ﹤0.01% 1641
2019
Q3 		$8K Buy
+200
New +$7.98K ﹤0.01% 1498
2019
Q2 		– Sell
-163
Closed -$6K – 1891
2019
Q1 		$6K Buy
+163
New +$6.36K ﹤0.01% 1599

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rockefeller Capital Management's PCRX Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Pacira BioSciences (PCRX) stake by 30% in Q2 2026, selling an estimated $11K and leaving 1,078 shares worth $27.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3631.

Rockefeller Capital Management first reported a position in PCRX in Q1 2019 and has held it in 19 quarters since. The position peaked at $75K in Q1 2022. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Rockefeller Capital Management held 1,078 shares of Pacira BioSciences worth $27.4K as of Q2 2026.
  • Rockefeller Capital Management sold 465 Pacira BioSciences shares in Q2 2026, an estimated $11K.
  • Pacira BioSciences made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3631 holding.
  • Rockefeller Capital Management first reported a position in Pacira BioSciences in Q1 2019 and has held it in 19 quarters since.
  • Rockefeller Capital Management's Pacira BioSciences position peaked at $75K in Q1 2022.
  • 254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.